Pulmonary Tuberculosis

Infectious Diseases
5
Pipeline Programs
2
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
5
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GSK
GSKLONDON, United Kingdom
3 programs
3
BTZ-043Phase 21 trial
GanfeborolePhase 2
MeropenemPhase 21 trial
Active Trials
NCT05807399Recruiting390Est. Dec 2027
NCT02349841Completed46Est. Dec 2014
Alliance Pharmaceuticals
2 programs
2
LinezolidPhase 22 trials
TMC207Phase 22 trials
Active Trials
NCT03537495Completed36Est. Jul 2023
NCT02279875Completed113Est. Jul 2017
NCT01215110Completed68Est. Sep 2010
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
GSKBTZ-043
Alliance PharmaceuticalsLinezolid
Alliance PharmaceuticalsLinezolid
GSKMeropenem
Alliance PharmaceuticalsTMC207
Alliance PharmaceuticalsTMC207

Clinical Trials (6)

Total enrollment: 685 patients across 6 trials

NCT05807399GSKBTZ-043

PanACEA - STEP2C -01

Start: Apr 2023Est. completion: Dec 2027390 patients
Phase 2Recruiting
NCT03537495Alliance PharmaceuticalsLinezolid

Pharmacokinetic Study of Linezolid for TB Meningitis

Start: Jun 2021Est. completion: Jul 202336 patients
Phase 2Completed
NCT02279875Alliance PharmaceuticalsLinezolid

A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

Start: Nov 2014Est. completion: Jul 2017113 patients
Phase 2Completed
NCT02349841GSKMeropenem

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

Start: Sep 2014Est. completion: Dec 201446 patients
Phase 2Completed
NCT01215110Alliance PharmaceuticalsTMC207

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

Start: Apr 2010Est. completion: Sep 201068 patients
Phase 2Completed
NCT02216331Alliance PharmaceuticalsTMC207

PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)

Start: Mar 2010Est. completion: May 201032 patients
Phase 1Completed

Related Jobs in Infectious Diseases

Value Stream Engineer II

GSK
Singapore - Tuas
10h ago

Value Stream Engineer I

GSK
Singapore - Tuas
10h ago

Value Stream Engineer II

GSK
Singapore - Tuas
10h ago

Internship - Process & Project Engineering (Hepatitis B), Singapore (July to December 2026)

GSK
Singapore - Tuas
10h ago

Production Technician

Sanofi
Swiftwater, PA
10h ago

Web Platform Full Stack Engineer

Sanofi
Barcelona
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 685 patients
2 companies competing in this space

Related Indications

HIV Infections(582)Influenza(316)COVID-19(238)Hepatitis C(201)HIV(178)Hepatitis B(148)HIV-1-infection(137)HIV Infection(108)Chronic Hepatitis B(105)Malaria(97)